Hungary-based predictive biology simulation firm Turbine has secured an investment from Accenture Ventures, the investment arm of Accenture. The financial terms of the funding were not disclosed. Turbine was the latest company to join Accenture's Project Spotlight, an investment program launched to provide financial and technical support to tech startups.
Turbine plans to use the acquired funds to expand its services to global biopharma companies to help expedite their drug development processes through Turbine’s biological insights.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.